EDITOR-IN-CHIEF: KAI ROSSEN H. Lundbeck A/S Ottiliavej 9 2500 Valby, Denmark + 4536301311
[email protected] ASSOCIATE EDITOR Angela Puchlopek-Dermenci
Qilong Shen Shanghai Institute of Organic Chemistry, CAS
Pfizer, Inc.
[email protected] [email protected] EDITORIAL ADVISORY BOARD Stefan Abele Idorsia Pharmaceuticals, Ltd., Switzerland
Matthias Beller Leibniz Institute for Catalysis, e.V., Germany
Stephane Caron Pfizer Worldwide R&D, U.S.A.
Donald Hou Chempartner Life Sciences, PR China
Guy Humphrey Merck & Co. Inc., U.S.A.
Dhileep Krishnamurthy Zhejiang NHU Company, Ltd., PR China
David A. Conlon U.S.A.
David Lathbury
Fridtjof Schröder Givaudan Schweiz AG, Switzerland
Christian H. Senanayake Boehringer Ingelheim Pharmaceuticals, Inc., U.S.A.
Hong Shen Roche R&D Center (China) Ltd., China
Kazuhiko Takahashi Sumitomo Dainippon Pharma Co., Ltd., Japan
Astute Chemical Development Madeleine Delamare Merial, France
Consultancy Ltd., U.K. Steven A. Weissman Lexicon Pharmaceuticals, U.S.A. Zhen Li
Claire Francis Scientific Update Ltd., U.K.
Xiaoyong Fu WuXi Apptec, China
Arrowhead Research Corporation, U.S.A.
Katherine Wheelhouse GlaxoSmithKline Medicines Research Centre, U.K.
Beth Lorsbach Dow AgroSciences LLC, U.S.A.
Atsuhiko Zanka Takeda Pharmaceutical Co., Ltd., Japan
Soo Bong Han Korea Research Institute of Chemical Technology, South Korea
Jaan Pesti EnginZyme AB, Sweden
Tony Zhang Eli Lilly and Company, U.S.A.
Stefan Hildbrand F. Hoffmann-La Roche Ltd., Switzerland
Yogesh S. Sanghvi
Jianrong (Steve) Zhou Nanyang Technological University, Singapore
Rasayan, Inc., U.S.A.
